Pil-Sang Song

Prof. Dr. Pil-Sang Song

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JKJoon-myoung Kwon
Joon-myoung Kwon
KKKyung-hee Kim
Kyung-hee Kim
KJKi-Hyun Jeon
Ki-Hyun Jeon
HKHyue Mee Kim
Hyue Mee Kim
MKMin Jeong Kim
Min Jeong Kim
BOByung-Hee Oh
Byung-Hee Oh
Kwon JM, et al. Korean Circ J. 2018 Aug;49:e56. https://doi.org/10.4070/kcj.2018.0446

1 December 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
WKWoochan Kwon
Woochan Kwon
JLJoo Myung Lee
Joo Myung Lee
KYKyeong Ho Yun
Kyeong Ho Yun
KCKi Hong Choi
Ki Hong Choi
SLSeung-Jae Lee
Seung-Jae Lee
FIfor The RENOVATE COMPLEX-PCI Investigators
for The RENOVATE COMPLEX-PCI Investigators
BACKGROUND: The RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance Versus Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) demonstrated that intravascular imaging–guided percutaneous coronary intervention (PCI) improved clinical outcome compared with angiography-guided PCI for patients with complex coronary artery lesions. This study aims to assess whether the prognostic benefit of intravascular imaging–guided procedural optimization persists in patients undergoing PCI for left main coronary artery disease. METHODS: Of 1639 patients enrolled in the RENOVATE-COMPLEX-PCI, 192 patients with left main coronary artery disease were selected for the current prespecified substudy. Selected patients were randomly assigned to either the intravascular imaging–guided PCI group (n=138) or the angiography-guided PCI group (n=54). The primary end point was target vessel failure defined as a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization. RESULTS: At a median follow-up of 2.1 years (interquartile range 1.1 to 3.0 years), intravascular imaging–guided PCI was associated with lower incidence of primary end point compared with angiography-guided PCI (6.8% versus 25.1%; hazard ratio, 0.31 [95% CI, 0.13–0.76]; P =0.010). This significant reduction in primary end point was mainly driven by a lower risk of cardiac death or spontaneous target vessel–related myocardial infarction (1.6% versus 12.7%; hazard ratio, 0.16 [95% CI, 0.03–0.82]; P =0.028). Intravascular imaging–guided PCI was independently associated with a lower risk of primary end point, even after adjusting for various clinical factors (hazard ratio, 0.29 [95% CI, 0.12–0.72]; P =0.007). CONCLUSIONS: Intravascular imaging–guided PCI showed clinical benefit over angiography-guided PCI for left main coronary artery disease in reducing the risk of cardiac death, target vessel–related myocardial infarction, or target vessel revascularization. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03381872.

1 January 2016 in Circulation Journal
Verified
Journal Article
Open access
PDF file
SCSang-Ryul Chung
Sang-Ryul Chung
TYTae-Hyun Yang
Tae-Hyun Yang
HSHo-Cheol Shin
Ho-Cheol Shin
HJHan-Young Jin
Han-Young Jin
JSJeong-Sook Seo
Jeong-Sook Seo
YKYoung-Jo Kim
Young-Jo Kim
Background:Total bilirubin (TB) concentration is inversely associated with stable coronary artery disease, but there have been few studies on initial TB in patients with ST-segment elevation myocardial infarction (STEMI).Methods and Results:A total of 1,111 consecutive patients with STEMI undergoing primary percutaneous coronary intervention (PCI) with drug-eluting stents (DES) were divided into a high TB group (n=295) and a low TB group (n=816) according to the optimal cut-off 0.79 mg/dl. The high TB group had a higher rate of in-hospital major adverse cardiac events (MACE), a composite of cardiac death, non-fatal MI, and definite/probable stent thrombosis (14.2% vs. 4.2%, P<0.001) and cardiac death (13.9% vs. 3.9%, P<0.001) compared with the low TB group. The 30-day MACE-free survival rate was also significantly different between the groups (P<0.001, log-rank test). On multivariate Cox regression, initial high TB was a significant predictor of in-hospital MACE (HR, 2.69; 95% CI: 1.67–4.34, P=0.010) and of cardiac death (HR 2.72, 95% CI: 1.67–4.44, P=0.012). Adding initial TB to TIMI risk score significantly improved prediction for in-hospital MACE according to net reclassification improvement (NRI=5.2%, P=0.040) and integrated discrimination improvement (IDI=0.027, P=0.006).Conclusions:Initial TB is a powerful prognostic marker, and inclusion of this can improve prediction of in-hospital MACE in patients with STEMI undergoing primary PCI with DES. (Circ J 2016; 80: 1437–1444)

19 April 2022 in Diabetes & Metabolism
Verified
Journal Article
Closed access
PSPil-Sang Song
Pil-Sang Song
KAKye Taek Ahn
Kye Taek Ahn
MKMi Joo Kim
Mi Joo Kim
SSSeok-Woo Seong
Seok-Woo Seong
SCSi Wan Choi
Si Wan Choi
JJJin-Ok Jeong
Jin-Ok Jeong

30 March 2014 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
PSPil-Sang Song
Pil-Sang Song
YSYoung Bin Song
Young Bin Song
JYJeong Hoon Yang
Jeong Hoon Yang
JHJoo-Yong Hahn
Joo-Yong Hahn
SCSeung-Hyuk Choi
Seung-Hyuk Choi
HGHyeon-Cheol Gwon
Hyeon-Cheol Gwon

1 July 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PSPil-Sang Song
Pil-Sang Song
YPYong Hwan Park
Yong Hwan Park
JOJu-Hyeon Oh
Ju-Hyeon Oh
YSYoung Bin Song
Young Bin Song
SCSeung-Hyuk Choi
Seung-Hyuk Choi
JHJoo-Yong Hahn
Joo-Yong Hahn